Genome‐wide linkage scan in Dutch hereditary non‐BRCA1/2 breast cancer families identifies 9q21‐22 as a putative breast cancer susceptibility locus
暂无分享,去创建一个
J. Houwing-Duistermaat | P. Devilee | H. Meijers-Heijboer | P. Nederlof | C. V. van Asperen | A. V. D. van den Ouweland | C. Cornelisse | R. Oldenburg | N. Hoogerbrugge | B. Bakker | H. Vasen | E. V. van Beers | J. Bayley | C. Dambrot | K. Kroeze-Jansema | Erik H. van Beers
[1] D. Weisenburger,et al. Downregulation of Death-Associated Protein Kinase 1 (DAPK1) in Chronic Lymphocytic Leukemia , 2007, Cell.
[2] A. Wallgren,et al. Genome‐wide linkage scan for breast cancer susceptibility loci in Swedish hereditary non‐BRCA1/2 families: Suggestive linkage to 10q23.32‐q25.3 , 2007, Genes, chromosomes & cancer.
[3] P. Nederlof,et al. Automated array-CGH optimized for archival formalin-fixed, paraffin-embedded tumor material , 2007, BMC Cancer.
[4] Barend Mons,et al. Text-derived concept profiles support assessment of DNA microarray data for acute myeloid leukemia and for androgen receptor stimulation , 2007, BMC Bioinformatics.
[5] Ajay N. Jain,et al. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. , 2006, Cancer cell.
[6] C. Plass,et al. 20q11.1 amplification in giant‐cell tumor of bone: Array CGH, FISH, and association with outcome , 2006, Genes, chromosomes & cancer.
[7] S. Seal,et al. A genome wide linkage search for breast cancer susceptibility genes , 2006, Genes, chromosomes & cancer.
[8] C. Wijmenga,et al. Reconstruction of a functional human gene network, with an application for prioritizing positional candidate genes. , 2006, American journal of human genetics.
[9] J. Houwing-Duistermaat,et al. Characterization of Familial Non-BRCA1/2 Breast Tumors by Loss of Heterozygosity and Immunophenotyping , 2006, Clinical Cancer Research.
[10] A. Mannermaa,et al. Refinement of the 22q12-q13 Breast Cancer–Associated Region: Evidence of TMPRSS6 as a Candidate Gene in an Eastern Finnish Population , 2006, Clinical Cancer Research.
[11] P. Nederlof,et al. A multiplex PCR predictor for aCGH success of FFPE samples , 2005, British Journal of Cancer.
[12] D. Easton,et al. Genetic Linkage Analysis in Familial Breast and Ovarian Cancer: Results from 214 Families , 2006 .
[13] Zheng Zhao,et al. Delineation of the minimal commonly deleted segment and identification of candidate tumor‐suppressor genes in del(9q) acute myeloid leukemia , 2005, Genes, chromosomes & cancer.
[14] Å. Borg,et al. Mapping of a novel ocular and cutaneous malignant melanoma susceptibility locus to chromosome 9q21.32. , 2005, Journal of the National Cancer Institute.
[15] Qian Tao,et al. The Stress-Responsive Gene GADD45G Is a Functional Tumor Suppressor, with Its Response to Environmental Stresses Frequently Disrupted Epigenetically in Multiple Tumors , 2005, Clinical Cancer Research.
[16] A. Jauch,et al. Comparison of genomic abnormalities between BRCAX and sporadic breast cancers studied by comparative genomic hybridization , 2005, International journal of cancer.
[17] Mark Daly,et al. Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..
[18] D. Easton,et al. An autosome-wide scan for linkage disequilibrium-based association in sporadic breast cancer cases in eastern Finland: three candidate regions found. , 2005, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[19] David M. Evans,et al. Guidelines for genotyping in genomewide linkage studies: single-nucleotide-polymorphism maps versus microsatellite maps. , 2004, American journal of human genetics.
[20] Douglas Easton,et al. The Genetic Epidemiology of Breast Cancer Genes , 2004, Journal of Mammary Gland Biology and Neoplasia.
[21] E. Gillanders,et al. Genome-wide scanning for linkage in Finnish breast cancer families , 2004, European Journal of Human Genetics.
[22] E. Gillanders,et al. Genome-wide scanning for linkage in Finnish breast cancer families , 2004, European Journal of Human Genetics.
[23] Sridhar Ramaswamy,et al. Loss of Heterozygosity and Its Correlation with Expression Profiles in Subclasses of Invasive Breast Cancers , 2004, Cancer Research.
[24] H. Ostrer,et al. Founder mutations among the Dutch , 2004, European Journal of Human Genetics.
[25] Jorma Isola,et al. Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization. , 2003, Cancer research.
[26] D. Easton,et al. EMGM Abstracts , 2003, Genetic epidemiology.
[27] L. V. van't Veer,et al. IVS10–6T>G, an ancient ATM germline mutation linked with breast cancer , 2003, Human mutation.
[28] L. V. van't Veer,et al. Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method. , 2003, Cancer research.
[29] N E Day,et al. A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes , 2002, British Journal of Cancer.
[30] G. Abecasis,et al. Merlin—rapid analysis of dense genetic maps using sparse gene flow trees , 2002, Nature Genetics.
[31] R. Goldbohm,et al. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease , 2001, The Lancet.
[32] Shu Ye,et al. PIRA PCR designer for restriction analysis of single nucleotide polymorphisms , 2001, Bioinform..
[33] P. Devilee,et al. Nearly all hereditary paragangliomas in The Netherlands are caused by two founder mutations in the SDHD gene , 2001, Genes, chromosomes & cancer.
[34] G. Giles,et al. After BRCA1 and BRCA2-what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer. , 2001, American journal of human genetics.
[35] E. Gillanders,et al. Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[36] K McPherson,et al. ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics. , 2000, BMJ.
[37] K McPherson,et al. Breast cancer—epidemiology, risk factors, and genetics , 1994, BMJ : British Medical Journal.
[38] S. Seal,et al. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. , 1999, Journal of the National Cancer Institute.
[39] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[40] Z. Paroush,et al. Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[41] L. Ala‐Kokko,et al. Conformation sensitive gel electrophoresis for simple and accurate detection of mutations: comparison with denaturing gradient gel electrophoresis and nucleotide sequencing. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[42] Z. Paroush,et al. Transcriptional repression by AML 1 and LEF-1 is mediated by the TLE y Groucho corepressors , 1998 .
[43] Peter Devilee,et al. BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients , 1997, Nature Genetics.
[44] S. Polak‐Charcon,et al. DAP kinase links the control of apoptosis to metastasis , 1997, Nature.
[45] G. Pals,et al. A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families. , 1997, American journal of human genetics.
[46] P. Schlag,et al. Strong indication for a breast cancer susceptibility gene on chromosome 8p12-p22: linkage analysis in German breast cancer families , 1997, Oncogene.
[47] L Kruglyak,et al. Parametric and nonparametric linkage analysis: a unified multipoint approach. , 1996, American journal of human genetics.
[48] S. Artavanis-Tsakonas,et al. Epithelial expression and chromosomal location of human TLE genes: implications for notch signaling and neoplasia. , 1996, Genomics.
[49] L. Sandkuijl,et al. Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds , 1995, Nature Genetics.
[50] L. Essioux,et al. Loss of heterozygosity and linkage analysis in breast carcinoma: indication for a putative third susceptibility gene on the short arm of chromosome 8. , 1995, Oncogene.
[51] J. Klijn,et al. Rapid detection of BRCA1 mutations by the protein truncation test , 1995, Nature Genetics.
[52] D. Easton,et al. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. , 1993, American journal of human genetics.
[53] N Risch,et al. Genetic analysis of breast cancer in the cancer and steroid hormone study. , 1991, American journal of human genetics.